Dexmedetomedine Infusion Versus Fentanyl Infusion for Donor Anlgesia During Living Donor Hepatectomy

Donor Hepatectomy Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02531529
• Other study ID #: LTx 1
• Status: Completed
• Phase: N/A
• First received: August 20, 2015
• Last updated: August 21, 2015
• Start date: January 2014
• Est. completion date: April 2015

Study information

• Verified date: August 2015
• Source: Mansoura University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Egypt: Ministry of Higher Education
• Study type: Interventional

Clinical Trial Summary

To compare between the analgesic effect of dexmedetomedine infusion versus Fentanyl infusion during donor hepatectomy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: April 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

• donors of living donor liver transplantation

Exclusion Criteria:

• patient refusal Known allergy to dexmedetomedine

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Donor Hepatectomy

Intervention

Drug:
• dexmedetomedine
intraoperative infusion
• Fentanyl

Locations

Country	Name	City	State
Egypt	Mansoura university	Mansoura	Dkahleya

Sponsors (1)

Lead Sponsor	Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative VAS scale		3 days	Yes